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Abstract 
This paper describes a software process 
development, assessment and improvement 
framework, structured to ensure regulatory 
compliance for the software developed in medical 
devices.  Software is becoming an increasingly 
important aspect of medical devices and medical 
device regulation. Medical devices can only be 
marketed if compliance and approval from the 
appropriate regulatory bodies of the Food and Drug 
Administration (US requirement), and the European 
Commission under its Medical Device Directives (CE 
marking requirement) is achieved. 
 Integrated into the design process of medical 
devices, is the requirement of the production and 
maintenance of a device technical file, incorporating 
a design history file.  Design history illustrates the 
well documented, defined and controlled processes 
and outputs, undertaken in the development of 
medical devices and for our particular consideration 
with this framework - the software components. 
1. Introduction 
 Of increased interest to medical device companies, 
particularly small businesses, is to enhance their 
software development processes beyond the sole 
need to ensure regulatory compliance, into an 
environment that integrates compliance, best 
practice and process improvement.  
 
Both patients and medical professionals have to rely 
on the proper functioning of medical devices that 
need to be operated safely. One of the main current 
issues is the assessment of appropriate safety 
integrity levels (SILs) for medical devices.  
The software framework introduced in this paper 
will address an opportunity to integrate the 
regulatory issues, process improvement mechanisms 
and safety integrity in order to achieve greater 
customer satisfaction, faster time to market and 
improved software quality.    
2. The medical device industry 
 
According to the Institute of Medicine report ‘To Err 
is Human’ [11], between 4400 to 9800 people die in 
hospital from preventative medical errors. The 
report also says that more people die every years a 
result of medical errors than from motor vehicle 
accidents, breast cancer or AIDS. 
 
Like most industries, the healthcare industry 
depends on computer technology to perform many 
of the functions ranging from financial management 
and patient information to patient treatment [12]. 
 
The use of software in medical devices has become 
widespread in the last two decades. Medical devices 
with software include those that are supplied and 
used entirely in hospitals and other health facilities, 
as well as consumer items such as blood pressure 
monitors. Many medical devices, and their software, 
operate in real time – monitoring, diagnosing, or 
controlling a physiological process as it changes.  
 
The complexity and risk profile of medical devices 
vary widely and range from a consumer digital 
thermometer for minor diagnosis, and an implanted 
artificial heart that is critical to preserving a patient’s 
life, to a therapeutic X-ray machine with a computer 
user interface, programmable software controlled 
therapy and anatomical and biophysical modelling in 
the software, which is operated under a high level of 
professional staff supervision [13]. 
 
A recent analysis of medical device recalls highlights 
the diverse nature of medical device software 
failures. The Federal Drug Administration (FDA) 
found that during 1983 – 1987 approximately 44% of 
the quality problems that led to voluntary recalls of 
medical devices were attributed to errors or 
deficiencies designed into particular medical devices 
rather than having been inserted during the 
manufacturing phase. The study also recognised 
software quality management practices as a means 
to prevent failure [14]. 
 
In the medical device industry, the software used to 
control a device takes on an additional role - it must 
help ensure the safety of the user and the patient. 
There are many challenges to implementing safe 
software. Software design needs to include 
deliberate engineering practices and rigorous risk 
analysis and mitigation needs to be performed 
whilst at the same time simultaneously addressing 
potential device failures that may be introduced by 




Medical device manufacturers, like businesses in 
most industries, have based the core of their quality 
system on the ISO9000:2000 [20] family of 
standards.  The internal quality system of each 
medical device company has then been enhanced to 
ensure compliance with additional standards that 
relate specifically to the nature of their products and 
the market they address.  ISO 13485:2003, Medical 
devices - Quality management systems - 
Requirements for regulatory purposes [29], for 
instance, is based on quality management system 
requirements currently contained in medical device 
regulations as well as those appropriate 
requirements contained in ISO 9001:2000. 
A recent study carried out by IQ Solutions with the 
medical device companies in N. Ireland has revealed 
that the software development process has been 
predominately based on the need to comply with 
the US Food and Drug Administration (FDA) [1] and 
European Medical Device Directives (MDD) [2] 
regulations.  The software life cycle process itself has 
not been of primary focus, only that the elements 
are in place that satisfy the regulatory requirements.   
 
It is believed that a Software Development Roadmap 
(SDR) and Software Process Improvement (SPI) 
exercise would greatly enhance the design control 
procedures currently being implemented in 
company quality systems.  The major rationale for 
accepting the software framework is to improve 
software quality and reduce time to market.  
Software quality is defined as software that meets 
its functional and non-functional requirements 
without lengthy rework, including regulatory 
compliance, without any inconsistencies.  Reducing 
time to market is often based on continuous 
improvement of processes implemented for the 
design, development and manufacture of medical 
devices and products. 
 
In addition, a recent survey undertaken by the 
Centre for Software Process Technologies (CSPT), 
indicated that N. Ireland health technology 
companies have limited awareness of standards 
applied to software development, such as 
ISO/IEC15504 (SPICE) [3].  Few organisations are 
aware of the concept of software process 
improvement and more alarmingly, the importance 
of software process improvement for increasing 
market penetration worldwide, particularly in the 
U.S.A.  If this is not addressed, health technology 
companies will experience difficulties in competing 
in markets where advanced software systems are 
required and time to market is crucial.   
 
Interestingly the prime factor here is not simply cost, 
but the quality agenda as a whole, with competitor 
companies possibly having already engaged in 
process improvement programs. Indeed, in 
countries such as China [4] there is considerable 
recognition of the importance of quality in software 
development with the Chinese government not only 
setting up government agencies with responsibility 
for building the maturity of the Chinese software 
industry but also offering subsidies to software 
enterprises that engage in SPI based maturity 
evaluations. 
 
4. SPI framework 
 
IQ Solutions and the CSPT are developing a software 
development framework for the medical device 
sector that integrates existing regulatory 
requirements for the control of the design, 
development, maintenance and support of software, 
with a software process improvement mechanism 
that will improve productivity, time to market and 
quality.  The framework is developed and delivered 
within the design control component of the ISO9000 
standard and related standards, thereby not 
requiring additional standard compliance and 
specific auditing by a notified body.  
 
The framework has received interest from other 
sources. There is a specific interest to address 
software in the medical device sector currently 
coming from Sweden, Italy, Germany, Switzerland 
and the USA. To channel this interest the SPICE User 
Group is to launch the MediSPICE initiative to bring 
the interested parties together. 
 
The approach for delivering an SPI framework is to 
establish a model (implemented as illustrated in 
figure 1) that addresses the specific software 
development requirements from relevant regulatory 
bodies, standards, customer expectations, and 
integrates those constraints with a SPI framework. 
The proposed SPI framework will be based on 
identifiable and relevant components of existing SPI 
models, such as ISO/IEC15504 (SPICE) and CMMI [5]. 
The model will be flexible in that relevant elements 
of the SPI framework may be adopted as required to 
provide the most significant benefit to the business.   
 
The major process improvement frameworks that 
currently exist, namely ISO/IEC15004 (SPICE) and 
CMMI, do not address regulatory requirements of 
the medical device industry. The US Food and Drug 
Administration (FDA) and the European Medical 
Device Directives (MDD) are the regulatory 
standards that control the design, development, 
manufacturing and support of products within the 






























Figure 1: Software framework model 
5. Project Outline 
In order to deliver an endorsed framework it was 
essential that a steering group was formed with 
members from various medical device companies 
and a notified body with experience in auditing 
medical device companies.  The involvement of 
medical device companies also adds an ownership 
element to the model and should improve its 
acceptance and implementation within each 
company.   
 
The software development model will cover the 
complete lifecycle, defined by default, as the V-
Model in 
 2.  No restriction will be made on the development 
life cycle processes undertaken by individual 
companies, although it is understood that 
companies within the medical device sector typically 
implement this V-Model.  The model will be 
expanded to incorporate applicable aspects of 
software improvement programs such as 
ISO/IEC15504 (SPICE) in addition to checking that all 
applicable standards and regulations are adhered to 
in a seamless manner and are focused upon 
software process improvement.  
 
The framework will also ensure that developed, 
reused or off-the-shelf [6] software satisfies 
functional, operational and regulatory requirements 
throughout the system lifecycle.  As each stage of 
the life cycle can be performed using various 
methodologies and project management processes, 
the model will be flexible to support the 
implementation and integration of preferred 
methodologies into the framework. 
Figure 2:  Software lifecycle V model 
6. Design  
The framework will provide a software 
development roadmap, which complies with the 
regulatory guidance criteria, while introducing best 
practice techniques and methodologies that can be 
selected as required.  For example a risk 
management process can adopt a Failure Mode 
and Effects Analysis (FMEA) method of identifying, 
mitigating and tracking risk and hazard issues.  Also 
the continuous management of verification and 
validation testing can be controlled and planned 
under a structured Test Process Improvement (TPI) 
model. 
 
The framework will provide a means of assessing 
software engineering capability in twelve areas 
that have been defined by the FDA [7] as:   
 
1) Level of Concern 
2) Software Description 
3) Device Hazard and Risk Analysis 
4) Software Requirements Specification 
5) Architecture Design 
6) Design Specifications 
7) Requirements Traceability Analysis 
8) Development 
9) Validation, Verification and Testing [8] 
10) Revision Level History 
11) Unresolved Anomalies 
12) Release Version Number 
 
To ensure compliance whilst also achieving 
software process improvement the following six 
software process have been identified as areas to 
be focused upon as a mapping can be made from 
these process areas to the twelve areas listed 
above. 
 
1. Requirements Management 
2. Risk Management 
3. Project Management 
4. Configuration Management 
5. Verification, Validation and Testing 
6. Software Design and Development 
 
The model will help companies to measure their 
organisational capability and to track progression 
and achievements in each of the six process areas 
and against process capability levels defined in 
ISO/IEC 15504-2 [16].   
 
 
7. Assessment framework 
 
The assessment framework will provide a method 
for the assessment of software processes in 
medical device organisations. The framework will 
include an assessment model that will provide a 
structured approach for assessment and that may 
be used by organisations involved in the 
development, maintenance and support of 
software with the following purposes: 
 Understanding the state of a company’s 
own processes for process improvement; 
 Determining the capability of a company’s 
own processes for a particular contract; 
 Determining the capability of another 
organisation’s processes for a particular 
contract.  
 
The assessment model will include coverage of all 
associated medical device regulatory standards. 
The project will take a similar lead in the approach 
to defining the assessment model based on SPICE 
for Space (S4S) in the space sector, and 
AutomotiveSPICE in the automotive sector that 
have adapted the ISO/IEC 15504 assessment model 
to applicable domain standards. Additionally, the 
outcome will have similarities to the Capability 
Assessment Tool [10] that was developed by the 
Office of Government Commerce, in that it helps 
an organisation to measure organisational 
capability and to track progression and 
achievement in key process areas (with a mapping 
back to the twelve FDA key areas). 
 
The framework will not provide requirements but 
rather guidelines and recommendations and 
ensure it endorses the essence of the SPICE and 
CMMI frameworks.  
7.1. Contents of the framework 
 
The contents of the framework will include a 
description of the following: 
 Introduction to the framework; 
 Intended audience and implementation 
strategy; 
 Software Development Roadmap - a 
suggested step-by-step guide to developing 
software including: 
o Life cycle development models and 
milestones, 
o Roadmap checklists, 
o Recommended best practices; 
 Architecture consisting of: 
o An assessment model, 
o An assessment method, 
o Assessment activities; 
 Process assessment and improvement 
concepts 
o Process improvement, 
o Process capability determination, 
 Compliance with medical device 
regulations; 
7.2. Software development roadmap 
 
Of key importance to medical device companies is 
a model that identifies the major software 
development activities and indicates how they 
should be undertaken not only to achieve 
complete, efficient and timely software 
development projects, but that also provides 
complete regulatory compliance and operates 
within recommended guidelines.  
The roadmap will be based on the V-Model as 
illustrated in figure 2, which is commonly accepted 
as the default product development model and is 
recommended under FDA guidelines [7]. 
It is the intention of the framework not only to 
encourage the implementation of a process model 
outlining specific development phases and how 
they interact, but also to examine how these 
phases are undertaken for their content, 
completeness and coverage.  In this circumstance 
best practices from the software industry will be 
presented and checklists will be provided. 
7.3.  Process Assessment 
Process assessment is an integral part of software 
process improvement and (see Figure 3) [9] 
provides a way to measure the capability of 
selected processes in an organisation against a 
target capability profile. Analysis of the assessment 
results enables companies to prioritise which 
processes should be improved in order to increase 
their effectiveness in achieving their business 
goals. The assessment results will also indicate the 
risks involved in undergoing a project using the 
assessed processes. This enables determination of 
how effective they are in achieving their goals, and 
to identify significant causes of poor quality, or 
overruns in time or cost. These provide the criteria 
to prioritise process improvements. 
 
Conformance assessments will be performed with 
the objective of determining how a company’s 
processes adhere to the framework. The 
assessments will be based on the interpretation of 
both the company’s historical business and 
product development information and metrics, 
and on the rating scheme used in the process 
assessment. When performing a conformance 
assessment any requirements that are specified by 
the regulatory bodies (e.g. FDA regulations) will 



































 7.3.1. Process assessment model. The process 
assessment model is composed of two main 
components: 
 
 Process areas  
 Capability scale.  
The process area component is introduced by listing 
the process areas that are deemed applicable to the 
medical device industry. A description of each 
process area is complemented with details of how to 
fulfil the criteria of the process area. In addition a list 
of potential work outputs are represented together 
with their corresponding term in associated medical 
device standards.  
 
The capability scale section is introduced by listing 
the capability scale against which each process is 
measured. The capability scale will be based upon 
ISO/IEC 15504-2 capability scales.  
 
7.3.2. Process Assessment activities. A medical 
device software process assessment will consist of 





 Information and metrics acquisition; 
 Information and metrics validation; 
 Process rating; 
 Reporting and inputs to the risk 
management process. 
 
A detailed breakdown of each activity into tasks will 
be described in the framework. Each process 
included in the assessment will be assessed on the 
basis of available evidence.  
 
The evidence may be gathered using interview, 
inspecting organisational documents or analysing 
metrics. The information collected for each process 
area will meet assessment objectives and scope. 
Information that supports a particular process rating 
will be recorded and maintained as evidence to 
substantiate the ratings and to verify compliance 
with the requirements. 
7.3.3. Risk management. The framework will 
include a last important step “Reporting and 
providing inputs to the Risk Management Process”.  
The risk management process area is both a 
process area and the final step of the assessment 
activities, as it is important that risk management 
is assigned a separate process area and that issues 
found in other process areas are also reported into 
the risk management process. This is particularly 
important to software developed or implemented 
in the medical device industry, as it is necessary to 
implement a risk management strategy throughout 
development. The risk management guidelines 
within the framework will acknowledge and 
endorse the ISO14971:2000 standard for 
“Application of Risk Management to Medical 
Devices”.  
 
In addition to ISO14971, best practice models such 
as FMEA for medical devices will be introduced to 
identify, assess, reduce, accept, and control 
software risks in a systematic proactive, 
comprehensive and cost effective manner taking 
into account the project’s technical and 
programmatic constraints. Risk identification 
within the framework will consist of 5 stages 
 
Stage 1 – Creation of a forum for risk assessment. 
 
Stage 2 – Systematically identify risk. 
 
The Software Risk Taxonomy checklist (that 
includes checklists relating to the regulatory 
standards and the SEI Software Risk Taxonomy 
checklist [10]) is used as a tool to help identify 
risks.  
 
Stage 3 –Define the Risk Attributes 
 
Identified risks are clarified and major risk 
attributes such as the probability of occurrence, 
the loss to the project should it occur, and the time 
frame for action are defined. 
Stage 4 – Document the identified risk in a risk 
management form. 
 
Stage 5 – Communicate the identified risks to the 
stakeholders. 
 
Risks are prioritised according to their exposure 
(the probability of the risk occurring multiplied by 
the impact of the occurrence of this risk on the 
project). This enables project critical issues to be 
highlighted to management and if necessary to the 
steering group committee. 
 
The risk management process benefits from the 
inputs from the process assessment in aspects 
related to the identification of processes triggered 
by a project risk and an evaluation of potential risk.  
7.4. Software Process Improvement 
 
Software process improvement is a continuous 
process that an organisation follows in a cyclic 
improvement path [9]. Improvement will be 
achieved by following this path and adopting 
specific improvement measures such as the 
introduction of new or changed practices into 
established processes and removing inefficient 
practices. An important step within the software 
process improvement cycle is the gathering of 
information. This information is required to 
establish the current state and subsequently to 
confirm the improvements by comparing the initial 
process assessment results with the re-assessment 
results gathered after the implementation of the 
improvements. The degree of improvement 
depends on the assessment criteria used rather 
than the specific activities of the improvement 
process.  
 
The framework will provide guidelines for the 
implementation of each of the activities in the 
improvement cycle as well as the expected results. 
Additionally, guidelines will to be provided in terms 
of recognition of improvement results. 
 
8. Safety Integrity levels 
 
Patients and medical professionals have to rely on 
the proper functioning of medical devices that 
need to be operated safely. The different 
stakeholders in the medical domain need to assess 
user needs, identify context specific risks, and 
specify functional requirements within a variety of 
operational contexts [17].  
 
One of the main current issues is the assessment of 
appropriate safety integrity levels (SILs) for medical 
devices. The topic of SILs requires special 
consideration with regard to the weighting of 
expected benefits of therapeutic or diagnostic 
functions against risks for patients in different 
classes of initial health condition. 
 
Active medical devices are more and more 
dependent on and controlled by programmable 
electrical/electronic (PE) systems. IEC 61508 [18] is 
an international standard for functional safety of 
electrical and/or electronic and/or programmable 
electronic (E/E/PE) safety related systems. IEC 
61508 defines appropriate means for achieving 
functional safety in the system. Part 3 of the7-part 
standard concerns itself with Software 
Requirements. 
 
The range of E/E/PE safety-related systems to 
which IEC 61508 can be applied includes other 
areas in addition to medical devices for instance: 
 
 Emergency shut down systems; 
 Crane automatic safe-load indicators; 
 Guard interlocking and emergency stopping 
systems for machinery; 
 Railway signalling systems; 
 Fly-by-wire operation of aircraft flight 
control surfaces; 
 Automobile anti-lock braking systems; 
 Remote monitoring, operation or 
programming of network-enabled process 
plant. 
 
As a general standard for safety, the IEC 61508 
standard defines four Safety Integrity Levels (SIL). 
The levels are specified in terms of average 
probability of failures per usage for low demand 
systems and probability of failures per hour for 
high demand (continuous usage) systems. 
 
IEC 61508 recommends the usage of a number of 
software practices for safety critical systems. These 
recommendations become more stringent as the 
required safety integrity level increases. The 
recommendations of the IEC 61508 standard focus 
on two productivity related parameters - one is 
termed software product verifiability and the other 
software process capability. 
 
Part 3 of the IEC 61508 standard relates to 
software requirements in safety critical systems. 
The general requirements of Part 3 specify the 
employment of such processes as quality 
assurance, configuration management, 
documentation and planned and tracked life cycle. 
Part 3 also enumerates considerable number of 
recommended software practices.  
 
When performing a software process assessment it 
will increasingly become important to establish the 
relevant target capability level for a SIL. There is 
currently a wide ranging set of views that surround 
the ability to establish the relationship between 
capability / maturity levels and software criticality. 
There are several opposing opinions and 
approaches to the problem that need to be 
analyzed and validated before including in the 
assessment framework for medical devices. 
 
Some of the wide ranging views are detailed below:  
 
In using IEC 61508 SILs within the automotive 
sector, the MISRA guidelines [25,26] have made a 
basic assumption that an organization must have 
an ISO9001 software quality system at SIL level 0 
(lowest level). If this assumption is true then the 
starting point for any target levels would be 
capability level 3 for all processes encompassed 
within an ISO9001 quality system.  
 
In relating IEC 61508 SILs to ISO/IEC TR 15504 
Capability Levels empirical work from the SPICE 
trails and COCOMO II [19] has proffered a 
correspondence between SILs and CLs. The stated 
correspondence relates SILs 1-2 to CL2 and SILs 3-4 
to CLs 3-4 respectively for relevant engineering 
processes. Data collected from the SPICE trials 
however indicates that organizations do not live up 
to the required capability levels for safety critical 
applications. 
 
The literature provides many examples of 
practices, tools and techniques that are 
recommended for the different SIL levels 
[20,21,27]. The question then arises whether the 
relationship between SILs and CLs are two 
dimensional or three dimensional. Whilst there 
may be a relationship of practices to capability 
levels, there may also be a need to assess on a 
more rigorous basis work product characteristics 
and resource and infrastructure characteristics at 
all levels depending on the SIL.  
 
Sources at the Defense Systems Directorate (USA) 
and Defence Material Organization (Australia) 
state that there is no correlation between 
CMMI/CMM capability/maturity levels and 
integrity-levels / levels-of-assurance. Achieving a 
certain CMMI/CMM capability / maturity level 
does not guarantee the ability to develop high 
integrity systems. It is stated that it is easy to 
confuse between them if you are not familiar with 
CMMI and/or safety. 
 
Current initiatives within CMMI and iCMM are 
integrating an integrity assurance process area 
within the models to deliver a context for 
safety/security and the synthesizing and 
harmonizing of safety/security practices [23]. A 
similar viewpoint has been developed by the +SAFE 
initiative in Australia [24].  
 
There is also a raging debate in UK safety critical 
circles as to whether there is actually any evidence 
that the ‘accepted wisdom’ defined in the 
standards is effective?  [22]. It has been suggested 
that an ‘evidence based approach’ may be better 
than ‘accepted wisdom’ in process based 
standards. The standards themselves contain a lot 
of sensible advice and guidance albeit that not 
much about safety, only quality and reliability.  
 
9.  Conclusion 
 
The medical device industry in Northern Ireland is 
characterised by many small new-start indigenous 
companies. Of particular importance to these 
companies is the need to develop medical devices 
in full compliance with the appropriate regulatory 
bodies that govern the sale and marketing of 
medical devices throughout the world. The key 
business goals of - cost effective development and 
speed to market, are fundamental factors for all 
companies, but for small new-start companies this 
is critical. The studies and assessment of the local 
medical device industry illustrates that an 
assessment framework as proposed in this paper 
will provide a huge benefit to participating 
companies as business goals and regulatory 
compliance may both be achieved. Once the 
framework is established further work will need to 
be progressed to relate capability levels to safety 
integrity levels to address relationships between 
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